GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Valuation Rank

Vitrolife AB (OSTO:VITR) Valuation Rank


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Vitrolife AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Valuation Rank
Comparable Companies
OSTO:EKTA B OSTO:XVIVO OSTO:SECT B OSTO:GETI B OSTO:MCAP OSTO:CEVI OSTO:BICO OSTO:SEDANA OSTO:BACTI B OSTO:CRAD B ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA DXCM STE
Traded in Other Exchanges
VTRLY:USA 0YAY:UK VTFN:Germany
Address
Box 9080, Gothenburg, SWE, 400 92
Website
https://www.vitrolife.com
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.